Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2023 August;64(4) > The Journal of Cardiovascular Surgery 2023 August;64(4):382-8

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  CURRENT MANAGEMENT OF COMPLEX AORTO-ILIAC OCCLUSIVE DISEASE 

The Journal of Cardiovascular Surgery 2023 August;64(4):382-8

DOI: 10.23736/S0021-9509.23.12705-4

Copyright © 2023 EDIZIONI MINERVA MEDICA

language: English

Evolution of the covered endovascular reconstruction of the aortic bifurcation technique for complex aorto-iliac occlusive disease

Maria A. RUFFINO 1 , Tom J. KONINGS 2, Barend M. MEES 2

1 Department of Interventional Radiology, Ticino Vascular Center, Institute of Imaging of Southern Switzerland, Lugano Regional Hospital, Lugano, Switzerland; 2 Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands



INTRODUCTION: The covered endovascular reconstruction of aortic bifurcation (CERAB) technique was introduced as a more anatomical and physiological configuration of stents to overcome the limits of standard endovascular technique with kissing stenting in terms of patency and reintervention rates in the treatment of complex aorto-iliac occlusive disease in particular when the aortic bifurcation is involved. The purpose of this systematic review is to report the evolution of this technique during recent years.
EVIDENCE ACQUISITION: Data were retrieved from retrospective studies and case series excluding letters, editorial, and reviews conducted from 2000 to September 2022.
EVIDENCE SYNTHESIS: The literature analysis provided data on the evolution of CERAB technique and the current evidence about clinical results.
CONCLUSIONS: Since its introduction in 2009, CERAB technique has grown as a safe and effective endovascular therapeutic option for aorto-iliac occlusive disease. Data from prospective multicenter registries with dedicated stent grafts and comparative trials are needed to validate the technique.


KEY WORDS: Endovascular procedures; Stents; Arterial occlusive disease

top of page